Levels of a protein present in tumours could predict someone’s chances of surviving lung cancer and provide a new treatment, according to a study. Patients with high levels of TLR2 in early-stage lung cancer were found to have increased survival rates compared with those with lower levels. A drug compound that activates TLR2 was also…

Continue Reading